Petros Pharmaceuticals Inc (PTPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -32,511 | -11,022 | -12,615 | -12,924 | -9,442 |
| Depreciation Amortization | 10,205 | 3 | 4 | 7 | 6 |
| Income taxes - deferred | -646 | N/A | N/A | N/A | N/A |
| Accounts receivable | 933 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 2,024 | 1,659 | -927 | 1,718 | -200 |
| Other Working Capital | 13,094 | 1,106 | -976 | 2,736 | -1,704 |
| Other Operating Activity | 9,434 | 558 | 3,527 | 1,087 | 1,023 |
| Operating Cash Flow | $2,533 | $-7,697 | $-10,988 | $-7,377 | $-10,317 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -72 | -3 | -4 | -3 | -12 |
| Investing Cash Flow | $-72 | $-3 | $-4 | $-3 | $-12 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 29 |
| Debt Issued | 2,904 | N/A | N/A | N/A | N/A |
| Debt Repayment | -6,013 | N/A | N/A | N/A | N/A |
| Common Stock Issued | N/A | 20,441 | 1,331 | 21,933 | 6 |
| Other Financing Activity | 0 | 0 | 0 | -11 | 13,514 |
| Financing Cash Flow | $-3,109 | $20,441 | $1,331 | $21,922 | $13,549 |
| Beginning Cash Position | 2,794 | 16,113 | 25,774 | 11,231 | 8,010 |
| End Cash Position | 2,146 | 28,854 | 16,113 | 25,774 | 11,231 |
| Net Cash Flow | $-648 | $12,741 | $-9,660 | $14,543 | $3,220 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,533 | -7,697 | -10,988 | -7,377 | -10,317 |
| Capital Expenditure | -72 | -3 | -4 | -3 | -12 |
| Free Cash Flow | 2,461 | -7,700 | -10,992 | -7,379 | -10,328 |